Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment

Clinical trial NCT00585845 · TERMINATED

Trial details

NCT number: NCT00585845
Sponsor: Anza Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Epithelial Mesothelioma Adenocarcinoma of the Pancreas Carcinoma, Non-Small-Cell Lung Adenocarcinoma of the Ovaries

Start date: 2007-12-01
Primary completion: 2009-02-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.